Spironolactone May Reduce the Risk of Incident Rosacea
April 2013
in “
Journal of Investigative Dermatology
”
New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
Studysummary This study reports that spironolactone use was associated with a decreased risk of developing rosacea compared to other diuretics, particularly in current users without previous androgenic skin disease diagnoses.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer